Follow the カルナバイオサイエンス株式会社 share price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are quoted on JP JP, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, カルナバイオサイエンス株式会社 has logged 11 insider filings. Market capitalisation: €8.3bn. The latest transaction was filed on 16 March 2023 (Holding update). Among the most active insiders: Cantor Fitzgerald & Co.. All data is free.
11
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
19Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 22,784 of 26,120 companies
24.6
score / 100
Value
7
Quality
42
FCF yld-31%
Earn yld-31%
EV/EBITDA·
ROE-244%
Gross mgn67%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.